Aldeyra Therapeutics Inc (NAS:ALDX)
$ 3.91 0.12 (3.17%) Market Cap: 232.31 Mil Enterprise Value: 114.93 Mil PE Ratio: 0 PB Ratio: 2.05 GF Score: 43/100

Q1 2020 Aldeyra Therapeutics Inc Earnings Call Transcript

May 07, 2020 / 12:00PM GMT
Release Date Price: $2.83 (-3.41%)
Operator

Good morning and welcome to the Aldeyra Therapeutics First Quarter 2020 Financial Results Conference Call. (Operator Instructions)

At this time, I would like to turn the call over to Mr. Joshua Reed, the company's Chief Financial Officer. Please go ahead, sir.

Joshua Reed
Aldeyra Therapeutics, Inc. - CFO

Thank you and good morning, everyone. On the call with me are Dr. Todd Brady, Aldeyra's President and Chief Executive Officer; and David McMullin, our Chief Commercial Officer. Todd will begin with an overview of our recent highlights and upcoming clinical milestones. I will discuss our first quarter financial results. Todd will make some concluding comments, and then we'll take your questions.

Please note that this morning's conference call contains forward-looking statements regarding future events and the future performance of Aldeyra. Forward-looking statements include statements regarding the timing of planned clinical trial initiations; Aldeyra's possible or assumed future results of operations, expenses and financial position

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot